Cardiometabolic correlates and heritability of fetuin-A, retinol-binding protein 4, and fatty-acid binding protein 4 in the Framingham Heart Study. 2012

Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
National Heart, Blood, and Lung Institute's Framingham Heart Study, Framingham, MA 01702, USA.

BACKGROUND Fetuin-A, retinol-binding protein 4 (RBP4), and fatty-acid binding protein 4 (FABP4) are novel biomarkers that may link adiposity to insulin resistance and the metabolic syndrome (MetSyn). OBJECTIVE The aim of this study was to investigate the correlates of these three adiposity biomarkers in a large community-based sample. DESIGN, SETTING, PARTICIPANTS, AND OUTCOMES: Serum concentrations of fetuin-A, RBP4, and FABP4 were assayed in 3658 participants of the Third Generation Framingham Heart Study cohort (mean age 40 yr, 54% women). We used multivariable regression to cross-sectionally relate biomarkers to insulin resistance, cardiovascular risk factors, and the MetSyn. The genetic contribution to inter-individual variation in biomarker levels was assessed using variance-components analysis. RESULTS All three biomarkers exhibited sexual dimorphisms (levels higher in women for fetuin-A and FABP4 but greater in men for RBP4) and were associated positively with insulin resistance assessed using the homeostasis model, with high-sensitivity C-reactive protein, and with prevalent MetSyn (P<0.01 for all). The biomarkers showed distinct patterns of association with metabolic risk factors. RBP4 levels were correlated with body mass index only in unadjusted but not in adjusted models. None of the biomarkers were associated with prevalent diabetes in multivariable models. Circulating fetuin-A, RBP4, and FABP4 levels showed modest heritability, ranging from 15-44% (all P<0.0001). CONCLUSIONS In our large young- to middle-aged community-based sample, we observed that circulating levels of fetuin-A, RBP4, and FABP4 are associated with insulin resistance and with distinct components of MetSyn consistent with the multifactorial pathogenesis of metabolic dysregulation.

UI MeSH Term Description Entries
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008297 Male Males
D008404 Massachusetts State bounded on the north by New Hampshire and Vermont, on the east by the Atlantic Ocean, on the south by Connecticut and Rhode Island, and on the west by New York.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
March 2022, Metabolites,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
September 2022, Circulation research,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
December 2012, Atherosclerosis,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
October 2023, Polish archives of internal medicine,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
October 2023, Cardiovascular toxicology,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
August 2013, Hepatology (Baltimore, Md.),
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
November 2016, Hepatology (Baltimore, Md.),
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
February 2004, Circulation,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
September 2009, Clinica chimica acta; international journal of clinical chemistry,
Bernhard M Kaess, and Danielle M Enserro, and David D McManus, and Vanessa Xanthakis, and Ming-Huei Chen, and Lisa M Sullivan, and Cheryl Ingram, and Christoper J O'Donnell, and John F Keaney, and Ramachandran S Vasan, and Nicole L Glazer
May 2022, Chinese medical journal,
Copied contents to your clipboard!